Preventive Behaviors and Seroprevalence of SARS-CoV-2 Antibodies from Natural Infection among Immigration Police Working at Don Mueang International Airport, Thailand, before the COVID-19 Vaccination Era
DOI:
https://doi.org/10.59096/osir.v16i1.261880Keywords:
COVID-19, SARS-CoV-2, antibody, preventive behavior, seroprevalence, immigration policeAbstract
After the first wave of the COVID-19 pandemic in Thailand in 2020, there was no data related to preventive behaviors against COVID-19 infection and prevalence of previous infections among frontline immigration police, which could be used to implement health promotion and adapt preventive methods in the organization. All frontline immigration police officers working at Don Mueang International Airport, Bangkok, were invited to participate in this cross-sectional study in May 2020. The objectives were to describe their preventive behaviors and determine the prevalence of antibodies against SARS-CoV-2 using conventional neutralization assays and ELISA tests. There were 201 eligible participants. All were asked to fill in a questionnaire, which asked them to disclose their preventive behaviors against COVID-19 infection. All were tested for antibodies against SARS-CoV-2 from natural infection as vaccines were not available at that time. The most practiced preventive behaviors were wearing a mask at work and wearing a mask in daily life, while taking sick leave when suffering from respiratory symptoms was the least practiced behavior. No SARS-CoV-2 antibodies were present in any participant. Reasons for not taking sick leave, when necessary, should be investigated in further qualitative studies.
References
Research and Markets. China outbound tourists visit and spending report 2019 - forecast to 2025 for the $365 billion industry [Internet]. Chicago: PR Newswire; 2019 Sep 25 [cited 2021 Jul 17]. <https://www.prnewswire.com/news-releases/china-outbound-tourists-visit-and-spending-report-2019---forecast-to-2025-for-the-365-billion-industry-300925281.html>
Department of Disease Control. Corona Virus Disease 2019 (COVID-19) [Internet]. 2020 [cited 2023 Mar 14]. <https://media.thaigov.go.th/uploads/public_img/source/310364.pdf>
Nilsson A, Holm D, Justesen U, Gorm-Jensen T, Andersen N, Ovrehus A, et al. Comparison of six commercially available SARS-CoV-2 antibody assays—choice of assay depends on intended use. Int J Infect Dis. 2021 Feb;103:381–8. doi:10.1016/j.ijid.2020.12.017.
Lerdsamran H, Mungaomklang A, Iamsirithaworn S, Prasertsopon J, Prasert K, Intalapaporn P, et al. Evaluation of different platforms for the detection of anti-SARS coronavirus-2 antibodies, Thailand. BMC Infect Dis. 2021 Dec 6;21(1):1213. doi:10.1186/s12879-021-06921-y.
Zonneveld R, Jurriaans S, van Gool T, Hofstra J, Hekker T, Defoer P, et al. Head-to-head validation of six immunoassays for SARS-CoV-2 in hospitalized patients. J Clin Virol. 2021 Jun;139:104821. doi:10.1016/j.jcv.2021.104821.
Manenti A, Maggetti M, Casa E, Martinuzzi D, Torelli A, Trombetta C, et al. Evaluation of SARS-CoV-2 neutralizing antibodies using a CPE - based colorimetric live virus micro - neutralization assay in human serum samples. J Med Virol. 2020 Oct;92(10):2096–104. doi:10.1002/jmv.25986.
Rosadas C, Khan M, Parker E, Marchesin F, Katsanovskaja K, Sureda-Vives M, et al. Detection and quantification of antibody to SARS CoV 2 receptor binding domain provides enhanced sensitivity, specificity and utility. J Virol Methods. 2022 Apr;302:114475. doi:10.1016/j.jviromet.2022.114475.
Tan C, Chia W, Qin X, Liu P, Chen M, Tiu C, et al. A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction. Nat Biotechnol. 2020 Sep;38(9):1073–8.
Luvira V, Leaungwutiwong P, Thippornchai N, Thawornkuno C, Chatchen S, Chancharoenthana W, et al. False positivity of anti-SARS-CoV-2 antibodies in patients with acute tropical diseases in Thailand. Trop Med Infect Dis. 2022 Jul 12;7(7):132. doi:10.3390/tropicalmed7070132.
Tartari E, Saris K, Kenters N, Marimuthu K, Widmer A, Collignon P, et al. Not sick enough to worry? "Influenza-like" symptoms and work-related behavior among healthcare workers and other professionals: results of a global survey. PLOS ONE. 2020 May 13;15(5):e0232168. doi:10.1371/journal.pone.0232168.
Barnes MC, Buck R, Williams G, Webb K, Aylward M. Beliefs about common health problems and work: A qualitative study. Soc Sci Med. 2008 Aug;67(4):657–65. doi:10.1016/j.socscimed.2008.05.008.
Dew K, Keefe V, Small K. ‘Choosing’ to work when sick: workplace presenteeism. Soc Sci Med. 2005 May;60(10):2273–82. doi:10.1016/j.socscimed.2004.10.022.
Bellaby P. What is genuine sickness? the relation between work-discipline and the sick role in a pottery factory. Sociol Health Illn. 1990 Mar;12(1):47–68.
Bloor M. Observations of shipboard illness behavior: Work discipline and the sick role in a residential work setting. Qual Health Res. 2005 Jul;15(6):766–77. doi:10.1177/1049732305276735.
Pichler S, Wen K, Ziebarth N. COVID-19 Emergency Sick Leave Has Helped Flatten The Curve In The United States. Health Affairs. 2020 Dec;39(12):2197-2204. doi:10.1377/hlthaff.2020.00863.
World Health Organization. Transmission of SARS-CoV-2: implications for infection prevention precautions [Internet]. Geneva: World Health Organization; 2020 Jul 9 [cited 2021 Aug 15]. <https://www.who.int/news-room/commentaries/detail/transmission-of-sars-cov-2-implications-for-infection-prevention-precautions>
National Center for Immunization and Respiratory Disease, Division of Viral Disease. COVID-19 and your health [Internet]. Atlanta (GA): Centers for Disease Control and Prevention (US); 2021 [cited 2021 Aug 15]. <https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html>
Cleaning tips to help keep COVID-19 out of your home [Internet]. New York: UNICEF; 2020 Sep 14 [cited 2021 Aug 15]. <https://www.unicef.org/coronavirus/cleaning-and-hygiene-tips-help-keep-coronavirus-covid-19-out-your-home>
Tips for keeping COVID-19 out of your home: how cautious should you be about cleaning surfaces and accepting packages? [Internet]. Cleveland (OH): Cleveland Clinic; 2020 Dec 24 [updated 2021 Apr 7, cited 2021 Aug 15]. <https://health.clevelandclinic.org/tips-for-keeping-your-home-clean-in-the-time-of-covid-19/>
Banchongduang S. More Thais see cashless future. Bangkok Post [Internet]. 2019 Apr 4 [cited 2021 Sep 26]; Business: [about 2 p.]. <https://www.bangkokpost.com/learning/easy/1656140/more-thais-see-cashless-future>
Akter S, Roy P, Ferdaus A, Ibnat H, Alam A, Nigar S, et al. Prevalence and stability of SARS-CoV-2 RNA on Bangladeshi banknotes. Sci Total Environ. 2021 Jul 20;779:146133. doi:10.1016/j.scitotenv.2021.146133.
Corpet D. Why does SARS-CoV-2 survive longer on plastic than on paper? Med Hypotheses. 2021 Jan;146:110429. doi:10.1016/j.mehy.2020.110429.
Elbadawy H, Khattab A, Alalawi A, Dakilallah Aljohani F, Sundogji H, Mahmoud A, et al. The detection of SARS-CoV-2 in outpatient clinics and public facilities during the COVID-19 pandemic. J Med Virol. 2021 May;93(5):2955–61. doi:10.1002/jmv.26819.
Riddell S, Goldie S, Hill A, Eagles D, Drew T. The effect of temperature on persistence of SARS-CoV-2 on common surfaces. Virol J. 2020 Oct 7;17(1):145. doi:10.1186/s12985-020-01418-7.
National Center for Immunization and Respiratory Diseases, Division of Viral Diseases. Science Brief: SARS-CoV-2 and surface (fomite) transmission for indoor community environments [Internet]. Atlanta (GA): Centers for Disease Control and Prevention (US); 2021 Mar 24 [updated 2021 Apr 5, cited 2022 Aug 31]. <https://www.cdc.gov/coronavirus/2019-ncov/more/science-and-research/surface-transmission.html>
Meister TL, Dreismeier M, Blanco EV, Bruggemann Y, Heinen N, Kampf G, et al. Low risk of severe acute respiratory syndrome coronavirus 2 transmission by fomites: a clinical observational study in highly infectious coronavirus disease 2019 patients. J Infect Dis. 2022 Nov 1;226(9):1608–15. doi:10.1093/infdis/jiac170.
Ripperger TJ, Uhrlaub JL, Watanabe M, Wong R, Castaneda Y, Pizzato HA, et al. Orthogonal SARS-CoV-2 serological assays enable surveillance of low-prevalence communities and reveal durable humoral immunity. Immunity. 2020 Nov 17;53(5):925-933.e4. doi:10.1016/j.immuni.2020.10.004.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Outbreak, Surveillance, Investigation & Response (OSIR) Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
